Australian healthcare company, Neo Health, has joined the Generic and Biosimilar Medicines Association (GBMA) as its first ‘Affiliate Member’, marking the ongoing growth of the peak body for affordable medicines. Reflecting the diversity of the healthcare eco-system, GBMA created the entry-level membership tier for medicine and technology manufacturers, suppliers, industry associations and patient groups, with aligned values and views. GBMA’s Independent Chair, Prof Jane Halton, said the Board and members all welcomed Neo Health at an important time in the medicine policy landscape with cost-of-living pressures and the increasing rate of chronic disease among Australians. Neo Health is an Australian-based company specialising in over-thecounter, prescription, wellness, and personal care solutions. The company aims is to provide products for all therapeutic categories, across multiple channels and global markets. With connections across the affordable-medicines sector, an Affiliate membership of the GBMA was a ‘positive and strategic’ fit, according to Neo Health Managing Director, Aman Madan (pictured). “We share GBMA’s core objectives to ensure all Australians have secure supply and timely access to high-quality, safe and affordable medicines,” Madan said. GBMA’s Chief Executive Officer, Marnie Peterson, said the GBMA is working closely with the Government, members and stakeholders to develop and implement effective policy reforms that better protect patients against the cost-of-living increases. “The GBMA looks forward to working with Neo Health and all members to ensure Australian patients can continue to access affordable, high-quality medicines, and support those most in need,” Peterson concluded. JG